CE - Celanese Corporation
NYSE
->
Basic Materials
->
Chemicals
Irving,
United States
Type: Equity
CE price evolution
CE
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1185 | $1483 | $1805 | |
| Short term investments | ||||
| Net receivables | $2055 | $1926 | $1825 | $1784 |
| Inventory | $2562 | $2464 | $2354 | $2357 |
| Total current assets | $5706 | $5904 | $5945 | $6218 |
| Long term investments | $1215 | $1238 | $1220 | |
| Property, plant & equipment | $5852 | $5763 | $5867 | $6006 |
| Goodwill & intangible assets | $10743 | $10828 | $10952 | |
| Total noncurrent assets | $19908 | $20088 | $20379 | |
| Total investments | $1215 | $1238 | $1220 | |
| Total assets | $25892 | $25812 | $26033 | $26597 |
| Current liabilities | ||||
| Accounts payable | $1446 | $1538 | $1447 | $1510 |
| Deferred revenue | ||||
| Short long term debt | $1977 | $2439 | $1383 | |
| Total current liabilities | $4159 | $4626 | $4925 | $4072 |
| Long term debt | $11324 | $11340 | $11018 | $12626 |
| Total noncurrent liabilities | $13577 | $13577 | $14973 | |
| Total debt | $13317 | $13753 | $14009 | |
| Total liabilities | $18618 | $18203 | $18962 | $19045 |
| Shareholders' equity | ||||
| Retained earnings | $13091 | $13051 | $12973 | $12929 |
| Other shareholder equity | -$727.02 | -$792 | -$797.02 | -$744 |
| Total shareholder equity | $7166 | $7071 | $7091 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1805 | $1508 | $536 | $955 |
| Short term investments | $10 | $533 | ||
| Net receivables | $1784 | $2054 | $1667 | $1242 |
| Inventory | $2357 | $2808 | $1524 | $978 |
| Total current assets | $6218 | $6611 | $3807 | $3763 |
| Long term investments | $1220 | $1062 | $823 | $820 |
| Property, plant & equipment | $6006 | $5997 | $4429 | $4171 |
| Goodwill & intangible assets | $10952 | $11247 | $2147 | $1485 |
| Total noncurrent assets | $20379 | $19661 | $8168 | $7146 |
| Total investments | $1220 | $1062 | $833 | $1353 |
| Total assets | $26597 | $26272 | $11975 | $10909 |
| Current liabilities | ||||
| Accounts payable | $1510 | $1518 | $1160 | $797 |
| Deferred revenue | ||||
| Short long term debt | $1383 | $1306 | $791 | $496 |
| Total current liabilities | $4072 | $4068 | $2505 | $1973 |
| Long term debt | $12626 | $13373 | $3376 | $3435 |
| Total noncurrent liabilities | $14973 | $16099 | $4933 | $5041 |
| Total debt | $14009 | $15043 | $4167 | $3931 |
| Total liabilities | $19045 | $20635 | $7438 | $7014 |
| Shareholders' equity | ||||
| Retained earnings | $12929 | $11274 | $9677 | $8091 |
| Other shareholder equity | -$744 | -$518.02 | -$329 | -$328 |
| Total shareholder equity | $7091 | $5637 | $4189 | $3526 |
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2611 | $2569 | ||
| Cost of revenue | $2057 | $1956 | ||
| Gross Profit | $554 | $613 | ||
| Operating activities | ||||
| Research & development | $34 | $32 | ||
| Selling, general & administrative | $265 | $272 | ||
| Total operating expenses | $355 | $365 | ||
| Operating income | $199 | $248 | ||
| Income from continuing operations | ||||
| EBIT | $323 | $301 | ||
| Income tax expense | $33 | -$575 | ||
| Interest expense | $169 | $178 | ||
| Net income | ||||
| Net income | $121 | $698 | ||
| Income (for common shares) | $121 | $698 | ||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $10940 | $9673 | $8537 | $5655 |
| Cost of revenue | $8337 | $7293 | $5855 | $4362 |
| Gross Profit | $2603 | $2380 | $2682 | $1293 |
| Operating activities | ||||
| Research & development | $146 | $112 | $86 | $74 |
| Selling, general & administrative | $1075 | $824 | $633 | $482 |
| Total operating expenses | $948 | $1001 | $738 | $624 |
| Operating income | $1655 | $1379 | $1944 | $669 |
| Income from continuing operations | ||||
| EBIT | $1890 | $1810 | $2311 | $2341 |
| Income tax expense | -$790 | -$489 | $330 | $247 |
| Interest expense | $720 | $405 | $91 | $109 |
| Net income | ||||
| Net income | $1960 | $1894 | $1890 | $1985 |
| Income (for common shares) | $1960 | $1894 | $1890 | $1985 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $155 | $121 | $698 | |
| Operating activities | ||||
| Depreciation | $198 | $227 | $195 | |
| Business acquisitions & disposals | -$4 | |||
| Stock-based compensation | $10 | $10 | $4 | |
| Total cash flows from operations | $292 | $101 | $830 | |
| Investing activities | ||||
| Capital expenditures | -$105 | -$137 | -$128 | |
| Investments | $17 | |||
| Total cash flows from investing | -$342 | -$91 | -$151 | -$168 |
| Financing activities | ||||
| Dividends paid | -$230 | -$77 | -$77 | -$77 |
| Sale and purchase of stock | ||||
| Net borrowings | -$395 | -$157 | -$163 | |
| Total cash flows from financing | -$1124 | -$489 | -$259 | -$240 |
| Effect of exchange rate | $2 | -$10 | -$13 | $26 |
| Change in cash and equivalents | -$992 | -$298 | -$322 | $448 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $1960 | $1894 | $1890 | $1985 |
| Operating activities | ||||
| Depreciation | $739 | $478 | $378 | $356 |
| Business acquisitions & disposals | $532 | -$10541 | -$1115 | $1496 |
| Stock-based compensation | $40 | $60 | $95 | $28 |
| Total cash flows from operations | $1899 | $1819 | $1757 | $1343 |
| Investing activities | ||||
| Capital expenditures | -$568 | -$543 | -$467 | -$364 |
| Investments | $516 | -$501 | ||
| Total cash flows from investing | -$134 | -$11141 | -$1119 | $592 |
| Financing activities | ||||
| Dividends paid | -$305 | -$297 | -$304 | -$293 |
| Sale and purchase of stock | -$17 | -$1000 | -$650 | |
| Net borrowings | -$1088 | $10716 | $404 | -$472 |
| Total cash flows from financing | -$1456 | $10290 | -$1042 | -$1471 |
| Effect of exchange rate | -$12 | $4 | -$15 | $28 |
| Change in cash and equivalents | $297 | $972 | -$419 | $492 |
News
Fundamentals
| Market cap | $7.10B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 109.27M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 2.69 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.37 |
| Quick ratio | 0.76 |